Skip to main content
OpenTrials
Completed

NCT Number: NCT00065754

Brain Imaging and Pain in Irritable Bowel Syndrome

This study examines the mechanisms, including brain imaging of placebo analgesia

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Florida

Gainesville, Florida, 32610, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Irritable Bowel Syndrome
  • English speaking

Exclusion criteria

  • Chronic pain condition other than Irritable Bowel Syndrome
  • Medical condition that would contraindicate use of lidocaine
  • Clinical criteria for fibromyalgia
  • Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
  • Seropositive HIV
  • Pregnancy

Treatment and study plan

Placebo

Drug

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)
  • National Institute of Neurological Disorders and Stroke (NINDS)

Registry information

Official study title

Brain Imaging and Pain: Analysis of Placebo Analgesia

Important dates

Study start
2003
Primary completion
2007
Study completion
2007
First posted
Aug 1, 2003
Registry last updated
Sep 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.